Breast cancer screening with imaging: recommendations from the Society of Breast Imaging and the ACR on the use of mammography, breast MRI, breast ultrasound, and other technologies for the detection of clinically occult breast cancer.
Screening for breast cancer with mammography has been shown to decrease mortality from breast cancer, and mammography is the mainstay of screening for clinically occult disease. Mammography, however, has well-recognized limitations, and recently, other imaging including ultrasound and magnetic resonance imaging have been used as adjunctive screening tools, mainly for women who may be at increased risk for the development of breast cancer. The Society of Breast Imaging and the Breast Imaging Commission of the ACR are issuing these recommendations to provide guidance to patients and clinicians on the use of imaging to screen for breast cancer. Wherever possible, the recommendations are based on available evidence. Where evidence is lacking, the recommendations are based on consensus opinions of the fellows and executive committee of the Society of Breast Imaging and the members of the Breast Imaging Commission of the ACR.
Lee
Carol H
CH
Department of Radiology, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA. leec1@mskcc.org
Dershaw
D David
DD
Kopans
Daniel
D
Evans
Phil
P
Monsees
Barbara
B
Monticciolo
Debra
D
Brenner
R James
RJ
Bassett
Lawrence
L
Berg
Wendie
W
Feig
Stephen
S
Hendrick
Edward
E
Mendelson
Ellen
E
D'Orsi
Carl
C
Sickles
Edward
E
Burhenne
Linda Warren
LW
D001943:Breast Neoplasms / Q000175:diagnosis* / Q000556:secondary*; D005260:Female; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000592:standards*; D008327:Mammography / Q000592:standards*; D008403:Mass Screening / Q000592:standards*; D009382:Neoplasms, Unknown Primary / Q000175:diagnosis*; D017410:Practice Guidelines as Topic; D014481:United States